We review a number of kinetic studies investigating the role of PCSK9 in lipoprotein metabolism in humans including healthy individuals, subjects with GOF and LOF mutations in PCSK9, as well as in patients with obesity and elevated Lp(a). Here, PCSK9 is linked to obesity disorder.